Aehr Test Systems (AEHR) P/E Ratio History
Historical price-to-earnings valuation from 1998 to 2025
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 2, 2026, Aehr Test Systems (AEHR) trades at a price-to-earnings ratio of -287.9x, with a stock price of $37.43 and trailing twelve-month earnings per share of $-0.37.
The current P/E is 516% below its 5-year average of 69.2x. Over the past five years, AEHR's P/E has ranged from a low of 1.9x to a high of 385.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Technology sector median P/E of 25.2x, AEHR trades at a 1241% discount to its sector peers. The sector includes 345 companies with P/E ratios ranging from 0.0x to 199.1x.
Relative to the broader market, AEHR trades at a notable discount to the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our AEHR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Peer Comparison
P/E metrics vs. Semiconductor Test, Metrology and Inspection Equipment peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
KLACKLA Corporation | $201B | 50.2 | 1.59 | +50% |
TERTeradyne, Inc. | $50B | 92.0 | - | +5% |
NVMINova Ltd. | $13B | 76.3 | 2.11 | +34% |
ONTOOnto Innovation Inc. | $11B | 53.2 | 0.41Best | +65%Best |
FORMFormFactor, Inc. | $8B | 111.1 | 9.43 | -15% |
CAMTCamtek Ltd. | $7B | 69.2 | 1.98 | +50% |
INTTinTEST Corporation | $144M | 48.5Lowest | 27.65 | -70% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | Fri Feb 28 2025 00:00:00 GM | $9.64 | $0.78 | 12.4x | -86% |
| FY2025 Q2 | Fri Nov 29 2024 00:00:00 GM | $11.89 | $0.75 | 15.9x | -82% |
| FY2025 Q1 | Fri Aug 30 2024 00:00:00 GM | $15.21 | $0.99 | 15.4x | -82% |
| FY2024 Q4 | Fri May 31 2024 00:00:00 GM | $11.51 | $1.12 | 10.3x | -88% |
| FY2024 Q3 | $16.27 | $0.52 | 31.4x | -64% | |
| FY2024 Q2 | $22.96 | $0.71 | 32.4x | -63% | |
| FY2024 Q1 | $51.01 | $0.63 | 80.6x | -8% | |
| FY2023 Q4 | Wed May 31 2023 00:00:00 GM | $33.02 | $0.50 | 66.6x | -24% |
| FY2023 Q3 | $33.35 | $0.49 | 67.8x | -23% | |
| FY2023 Q2 | Wed Nov 30 2022 00:00:00 GM | $26.07 | $0.43 | 60.8x | -31% |
| FY2023 Q1 | Wed Aug 31 2022 00:00:00 GM | $14.54 | $0.33 | 44.6x | -49% |
| FY2022 Q4 | $8.38 | $0.33 | 25.2x | -71% |
Average P/E for displayed period: 87.8x
See AEHR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AEHR Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare AEHR vs NVDA
See how AEHR stacks up against sector leader NVIDIA Corporation.
Start ComparisonFrequently Asked Questions
Is AEHR stock overvalued or undervalued?
AEHR trades at -287.9x P/E, below its 5-year average of 69.2x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does AEHR's valuation compare to peers?
Aehr Test Systems P/E of -287.9x compares to sector median of 25.2x. The discount suggests lower growth expectations or higher risk.
What is AEHR's PEG ratio?
AEHR PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1998-2025.